Related Experiment Video
Updated: Sep 30, 2025
07:29
HPLC Coupled with Chemical Fingerprinting for Multi-Pattern Recognition for Identifying the Authenticity of Clematidis Armandii Caulis
Published on: November 11, 2022
2.1K
[COUNTERACTION TO CORRUPTION DURING PUBLIC PROCUREMENT OF MEDICINAL PRODUCTS]
B Lohvynenko1, A Podoliaka2, Yu Domin3
11Dnipropetrovsk State University of Internal Affairs; Ukraine.
Georgian Medical News
|March 10, 2022
Summary
Corruption risks in public medicine procurement are high, especially during emergencies. Electronic systems and stage-specific measures can help prevent corruption and protect public health.
Area of Science:
- Public Health
- Health Law
- Public Administration
Background:
- Corruption in public procurement of medicinal products poses significant risks to national economies and public health.
- Emergency situations exacerbate corruption risks in the procurement of essential medicines.
- Existing anti-corruption measures require improvement to address the specific vulnerabilities in healthcare procurement.
Purpose of the Study:
- To conduct a comparative analysis of corruption and corruption risks in public procurement of medicinal products in Ukraine and internationally.
- To identify effective strategies for counteracting corruption in this critical sector.
- To balance procurement efficiency with robust anti-corruption measures.
Main Methods:
- Comparative legal analysis of international and national legislation.
- Historical and legal research methods.
- Formal legal and system analysis methods.
- Application of formal logic.
Main Results:
- Corruption is a persistent issue in public procurement, with heightened risks during emergencies.
- Public procurement of medicinal products is particularly susceptible to corruption, impacting economy and public health.
- Electronic trading systems enhance transparency and accountability, serving as a tool to prevent corruption.
Conclusions:
- Addressing corruption in medicinal product procurement requires a balanced approach between speed, anti-corruption measures, and threat response.
- Understanding potential corruption at each procurement stage is crucial for developing targeted counteraction strategies.
- Implementing transparent electronic procurement systems is vital for mitigating corruption and safeguarding public health.
Related Concept Videos
01:03Drug Control Governance: Regulatory Bodies and Their Impact
268
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
268
01:25Drug Regulation
2.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.0K
01:19Pharmacovigilance
1.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.0K
01:02Prescription, Nonprescription and Orphan Drugs
876
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
876
01:17Antidotes
786
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
786
01:17Drug Nomenclature
2.4K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
2.4K